Drug interactions and possible serotonin syndrome in a patient with fibromyalgia

Authors

  • Patricia de Carvalho MASTROIANNI Universidade Estadual Paulista “Júlio de Mesquita Filho” - UNESP https://orcid.org/0000-0001-8467-7278
  • Fabiana Rossi VARALLO Universidade Estadual Paulista “Júlio de Mesquita Filho” - UNESP https://orcid.org/0000-0003-4016-1442
  • Manuel MACHUCA Unit of optimization of the pharmacotherapy

DOI:

https://doi.org/10.17533/udea.vitae.18143

Keywords:

bruxism, serotonin syndrome, medication therapy management, pharmaceutical care

Abstract

Depression associated with fibromyalgia can be treated with selective serotonin reuptake inhibitors (SSRI) as fluoxetine, paroxetine or citalopram; or with serotonin–norepinephrine reuptake inhibitors (duloxetine or milnacipran). In patients with fibromyalgia, several meta-analyses have demonstrated the effectiveness of antidepressants, particularly the tricyclic antidepressant (TCA) amitriptyline, which reduce the pain, fatigue, depression, and sleep disturbances. Additionally, tramadol, pregabalin, and gabapentin are other treatment options.

|Abstract
= 123 veces | PDF
= 40 veces|

Downloads

Download data is not yet available.

Author Biographies

Patricia de Carvalho MASTROIANNI, Universidade Estadual Paulista “Júlio de Mesquita Filho” - UNESP

School of Pharmaceutical Sciences, Department of Drugs and Medications. PhD, Assistant Doctor Professor

Fabiana Rossi VARALLO, Universidade Estadual Paulista “Júlio de Mesquita Filho” - UNESP

School of Pharmaceutical Sciences, Department of Drugs and Medications. PhD student

Manuel MACHUCA, Unit of optimization of the pharmacotherapy

PhD in Pharmacy. Clinical Pharmacist

References

Goldenberg DL. Pharmacological treatment of fibromyalgia and other chronic musculoskeletal pain. Best Pract Res Clin Rheumatol. 2007; 21: 499–511.

Miquel CA, Campayo JG, Fórez MT, et al. Documento de Consenso interdisciplinar para el tratamiento de la fribiomialgia. Acta Esp psiquiatr. 2010; 38 (2): 108-120.

Chu J, Wang RY, Hill NS. Update in clinical toxicology. Am J Respir Crit Care Med. 2002; 166 (1): 9-15

Jackson N, Doherty J, Coulter S. Neropsychiatric complications of commonly used palliative care drugs. Postgrad Med J. 2008; 84 (989): 121-126.

Schuman E. Serotonin toxicity revisited. Headache 2009; 49 (5): 784-785.

Strand LM, Cipolle RJ, Morley PC, Frakes MJ. The impact of pharmaceutical care practice on the practitioner and the patient in the ambulatory practice setting: twenty- five years of experience. Curr Pharm Des, 2004; 10 (31): 3987-4001.

Nelson EM, Philbrick AM. Avoiding serotonin syndrome: the nature of the interaction between tramadol and selective serotonin reuptake inhibitors

Downloads

Published

19-02-2014

How to Cite

MASTROIANNI, P. de C., VARALLO, F. R., & MACHUCA, M. (2014). Drug interactions and possible serotonin syndrome in a patient with fibromyalgia. Vitae, 21(1), 60–61. https://doi.org/10.17533/udea.vitae.18143

Issue

Section

Letter to Editor

Most read articles by the same author(s)

Similar Articles

1 2 3 4 5 6 7 8 > >> 

You may also start an advanced similarity search for this article.